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Abstract 
 The US and EU pharmacopeias require sub-visible particle (SbVP) testing of parenteral drug 
products by either light obscuration (LO) or light microscopy.1-3  According to the USP/EP, the LO method 
requires the use of four measurements consuming a total volume of 25 ml per sample.
1-3
 This large 
sample volume makes the compendia test not only cost-intensive for biopharmaceutics, but in certain 
cases impractical, especially in early stage development when clinical supplies are often limited. The first 
part of this work therefore presents a set of experimental data for evaluation of a small scale, lower 
volume LO method (1.2 ml per sample). Limitations for detecting various translucent particles such as 
glass splinters, silicone oil droplets and non-soluble protein aggregates have been considered for both of 
these LO methods. In addition, a relatively new technology – Micro Flow Digital Imaging (MDI) – has 
been introduced, which may be a viable add-on to measure SbVP.
4-7
  The purpose of the second phase of 
this research was to evaluate the advantages and limitations of MDI by directly comparing LO and MDI, 
and also by comparing two different MDI instruments (i.e., Micro Flow Imaging (MFI) and FlowCam), 
with regards to subvisible particle counts, size distribution and morphology parameter analysis. 
As protein subvisible particles vary widely in shape and size, it is difficult to quantitatively 
describe the limitations of MDI and LO for actual samples of a protein therapeutic drug. Moreover, real-
life protein formulations can differ in optical properties such as turbidity, color, refractive index which 
may potentially influence SbVP detection. During this work, MDI technologies have been improved for 
the use on a routine basis with protein samples (e.g., FlowCam counting ability was improved by adding 
a syringe pump for controlled flow, and MFI optical system was enhanced with the so called set-point 3).  
The effect of solution optical properties on SbVP particle sizing and counting was addressed 
subsequently using the latest MDI instrument and three different LO instruments. In addition, 
iv 
 
translucent particles such as glass and irregular shaped particles in development as “false protein 
standard” (to mimic properties of real life proteinaceous particles) were evaluated in this work. 
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Abbreviations 
α Alpha: Type I error rate 
β Beta: Type II error rate 
C colored suspensions 
CI  confidence interval 
CV coefficient of variation 
CVi coefficient of variation solely attributed to instrument response 
d effect size 
df Degrees of freedom 
Dp Particle diameter 
EP European Pharmacopeia 
FLO FlowCam 
HIA HIAC/Royco 9703 liquid syringe sampler 
LAF laminar air flow 
LO Light Obscuration 
M Mean 
mAb monoclonal antibody 
max Maximum 
MDI Microflow Digital Imaging 
Mdn Median 
MFI Micro Flow Imaging 
Mi Mean of a partial population 
N/n total population / partial population size 
p  probability for data under validity of H0 
PFS pre-filled syringe 
Ph.Eur. European Pharmacopeia 
R reference suspension 
ρφ density of the fluid 
pxl pixel 
Ri refractive index 
ρπ density of the particle 
SbVP sub-visible particles 
sd Standard Deviation (generally the sample-based population estimate using n-1 in the denominator) 
sd
2 Sample Variance 
SDVB Styrene divinyl benzene 
SE Standard Error 
SY6 Klotz Syringe with a 670nm Laser 
SY7 Klotz Syringe using a 780nm Laser 
T turbid suspension 
t  student  t-distribution 
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tcrit critical value of a t-distribution 
USP United Stated Pharmacopeia 
V viscous suspension 
WFI water for injection 
x particle counts 
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Introduction 
Sub-visible particles (SbVP) analysis is considered to be a key analytical test for parenteral drug 
products.8,9  The United States Pharmacopeia (USP) and European Pharmacopeia (EP) require sub-visible 
particle testing by light obscuration (LO) or light microscopy for parenteral products with corresponding 
compendia acceptance criteria.
1,3
 According to the USP/EP, the LO method indicates four measurements 
at a volume of 5 ml (with 5 ml remaining) resulting in a total volume of 25 ml per sample.
1-3
 This large 
sample volume makes the assay cost-intensive for biopharmaceutics.  As the name - light obscuration - 
implies, the degree of light blockage defines the particle size (Figure 1), but the LO method has been 
reported to have limitations for some types of translucent particles.
10
 Polystyrene particles are routinely 
used in calibration measurements of the LO method, however, protein particles have different shape 
and morphology as well as different optical properties compared to polystyrene particles.
2,6
 These 
differences may result in difficulties in correctly detecting and accurately quantifying protein-based 
subvisible particles within liquid biopharmaceutical samples using the LO method.
1,6,11
  
The major drawback of the standard microscope compendia methods for particle analysis is the 
time required, both for sample preparation and for counting and measuring size properties of the 
particles. In addition, sample preparation may alter the analytical readout, e.g. protein particles may 
theoretically dissolve during sample preparation or may be difficult to accurately detect on the filter 
surface. Recently, a new technique – microflow digital imaging (MDI) – has been introduced, which may 
be a viable add-on to assess protein-based sub-visible particles.
4-7,12
 The MDI technique captures images 
of particles as the analyzed sample is drawn through a flow-cell centered in a field of view, resulting in 
particle counts, particle sizing as well as additional particle shape information (Figure 1).
11
 Brightwell’s 
microflow imaging technology (MFI) overcomes the problems of static microscopy techniques (e.g., 
equipment vendor claims to be able to identify and separate different particle types) by simple software 
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filtering of subvisible particle property values including its capabilities for counting, sizing and analyzing 
translucent protein aggregates and particulates.
4,6,11,13,14
 
The main objectives of the first studies in this work were to assess a small volume LO method, to 
compare MFI and LO techniques regarding their particle counting abilities, and to evaluate MFI and a 
comparable technology, FlowCam, with regards to examining the morphologies of different types of 
particles. As non-soluble protein subvisible particles vary widely in morphology and size, it is difficult to 
quantitatively describe the limitations of MDI and LO for actual protein samples. Moreover real-life 
protein formulations also differ in optical properties such as turbidity, color, refractive index which may 
potentially influence SbVP detection. Further investigations were therefore made in the second part of 
this work to elucidate the capabilities of LO and MDI under controlled but more real-life protein 
formulation solution conditions. 
 
Principle of light obscuration Principle of microflow digital imaging 
  
Figure 1: measuring principles of light obscuration  (LO) and microflow digital imaging (MDI). 
Using LO the degree of light blockage defines the p article size whereas MDI technique captures 
images of particles as the analyzed sample is drawn  through a flow-cell. 
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The ideal sample for detecting subvisible particles would consist of a clear, water-like fluid with 
individual, freely dispersed particles of moderate buoyancy and high contrast (opacity, color, refractive 
index) such that each particle passing between the illuminator and sensor is effectively recognized.  An 
actual product sample that does not have the clarity and viscosity approximately equivalent to water 
may provide erroneous data when analyzed by LO counting method or MDI.
15,16
 For example, protein 
formulation characteristics such as color, viscosity or inherent solution properties may provide 
erroneous SbVP data. Due to its high molecular weight protein represents a significant volume fraction 
in protein formulations. Solution non-idealities caused by protein-protein interactions in protein 
formulations may result in high viscosities and opalescence.
17,18
 Opalescence originates from high 
aggregation levels, particle loads and phase separations (e.g. silicone and air bubbles). Coloration is 
observed in altered protein formulations and induced by degradation of absorbing amio acid residues 
like Cysteine, Histidine, Phenylalanine, Tryptophan and Tyrosine and reaction products with reducing 
sugars.  
Therefore, experiments were conducted to assess the robustness of LO and MDI methods for 
particle counting and sizing abilities using different sample fluids. Suspensions of particles in water-
based solutions were used in comparison to colored, turbid and viscous suspensions of the same 
particles. These suspensions were used to evaluate both particle counting and particle sizing using 
different sized opaque and translucent particles of both spherical and irregular shapes. 
 For example, in colored suspensions, the emitted light from the instrument can be absorbed by 
the particle and the fluid, potentially leading to relatively less light blocked by the particle than in 
colorless fluid. Coloration was therefore evaluated to determine if it artificially decreases the particle 
numbers counted by LO methods depending on the particle translucence, the overlap of the sample 
fluid absorbance, and the instrument emitting light wavelength. It was anticipated to only marginally 
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affect MDI methods because of the applied illumination optimization step (i.e., changing light intensity 
depending on sample properties) prior to each analysis. 
With regards to solution turbidity and viscosity, the effect of these solution properties on 
subvisible particle counting was also evaluated.  For turbidity, it was hypothesized that higher particle 
counts in the lower size range may be found due to noisy baselines when using MDI.  Due to light 
scattering effects, turbidity was assumed to lower image contrast, an effect potentially leading to 
apparent smaller particle size measurements and lower counts.  The influence of solution viscosity on 
the instrument’s particle counting ability was hypothesized to be highly affected when a particle 
interaction’s with light is mainly based on refraction. In addition, the effect of solution viscosity may also 
be dependent on the method itself: e.g., if there is a mixing phase during the beginning of the 
measurement, high particle counts may be observed due to the phase-mixing and potential air bubble 
formation, but also lower particle counts may be encountered if the specified flow rate cannot be 
maintained.
15
 In addition, scattering effects on small particles are highly affected by the difference in 
refraction. Lowering the difference in refraction was assumed to lower the apparent particle size and 
consequently it may highly influence particle counts at the lower size limit of the analytical method.  
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Materials and Methods 
Materials 
Actual Samples 
Proteinaceous Particles 
Proteinaceous particles were analyzed from two monoclonal antibodies (mAb) formulations 
provided by F. Hoffmann-La Roche Ltd. (Basel, Switzerland), termed mAb1 and mAb2 respectively. The 
formulation compositions for the two different mAb samples were as follows: mAb1: 50 mg/ml in 50mM 
phosphate buffer (pH 6.0) and mAb2 – 10 mg/ml in 25mM sodium acetate buffer (pH 6.0). The 
formulation was filtered using 0.22 µm Milipak-100 Gamma Gold PVDF (Millipore, Bedford, MA, USA) 
and aseptically filled into pre-sterilized 20 ml  glass type 1 vials (silicone-free), closed with teflon® coated 
20mm serum stoppers (Daikyo Inc., Tokyo, Japan) and crimped with aluminum caps (Helvoet Pharma, 
Karlsbad, Germany). The mAb1 samples were stored unopened in a controlled 2-8°C stability chamber 
for 3¼ years. Freeze-thaw stress (-80°C/+5°C, 1 cycle) was applied to mAb1 and mAb2 samples (termed 
“freeze-thaw stressed”). After thawing the samples were stored at 2-8°C for 24h before analysis. 
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Polysorbate Related Insoluble Particles 
Polysorbate related insoluble material was generated during storage of a protein solution of 
mAb3 (F. Hoffmann-La Roche Ltd.) at a concentration of 10 mg/ml containing 20mM citrate/sodium 
hydroxide buffer (pH 5.5), 190mM sucrose (Ferro, Mayfield Heughts, OH, USA), 20mM arginine-HCl 
(Ajinomoto, Kyobashi, Japan) and 0.02% (w/v) polysorbate 20 (Croda Inc., Snaith, UK) . These samples 
were prepared aseptically at a fill volume of 5.3 ml in 6 ml glass type 1 vials in the same procedure as 
mentioned above. Samples were stored in a controlled 2-8°C stability chamber for 17 months. The 
polysorbate 20 used was shown to be partially degraded and insoluble particles observed in the mAb3 
solution were identified has being non-proteinaceous in nature by a staining method which is specific 
for proteins.
19-21
 
Silicone Oil Droplets 
Silicone oil droplets were obtained using a placebo solution containing 140mM sodium chloride 
(Merck, NJ, USA), 25mM sodium acetate trihydrate (Merck, NJ, USA), 100mM benzyl alcohol (Sigma 
Aldrich, St. Luis, Missouri, USA), 0.05 % (w,v) polysorbate 80 (Croda Inc., Snaith, UK), 10mM glacial acid 
acetic (pH 6.0). The placebo solutions were stored in staked-in needle pre-filled syringe (PFS) 
(Gerresheimer, Düsseldorf, Germany), containing sprayed in silicone, in a temperature controlled 
stability chamber at 25°C for 6 months. 
Negative and positive controls were utilized at each testing session to ensure that the 
environment, sample preparation procedure, and instrument were all suitable for the analysis.  
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Particle Standards 
Dilution Media for Particle Standards 
Various types of particle standards were utilized for the comparison of the MDI and LO 
techniques in terms of particle sizing and counting capabilities. In order to stabilize the particle 
suspensions, a surfactant containing dilution media was used containing 0.02 % (w/v) polysorbate 20 
(Croda International, Snaith, England) in freshly drawn water for injections (WFI, distilled internally). This 
solution, termed “dilution media”, was sterile filtered using 0.22 µm Stericup-GV Filters (PVDF) 
membrane type (Millipore, Massachusetts, USA). 
Polystyrene Particles 
Polystyrene particles NIST particle size standards were obtained from Thermo Scientific 
(Fremont, CA, USA) with nominal particle sizes of 2, 5, 10 and 25 µm. Polystyrene particles NIST count 
standards were obtained from Thermo Scientific (Fremont, CA, USA) with nominal particle sizes of 2, 5, 
10 and 25 µm and concentrations of 2000 particles per ml as summarized in Table 1. 
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Table 1: Summary of physical properties of polystyr ene particle standards 
cat 
no 
nominal 
size 
certified 
mean 
diameter 
standard 
deviation 
uncertaint
y mean 
diameter 
microsphe
re density 
index of 
refraction 
approximate 
concentration 
Dp sd ρp  
 [µm] [µm] [µm] [µm] [g/cm
3
] at 589nm  
4202 2 1.999 0.022 0.02 1.05 1.59 0.44% solids 
4205 5 4.987 0.05 0.04 1.05 1.59 0.31% solids 
4210 10 10.00 0.09 0.08 1.05 1.59 0.23% solids 
4225 25 25.09 0.12 0.38 1.05 1.59 0.53% solids 
6002 2 1.998 0.022 0.02 1.05 1.59 2000/ml ± 10% 
≥1.3µm 
6005 5 5.010 0.035 0.05 1.05 1.59 2000/ml ± 10% 
≥3µm 
6010 10 10.00 0.05 0.09 1.05 1.59 2000/ml ±10% 
≥7.5µm 
6025 25 25.09 0.12 0.38 1.05 1.59 2000/ml ±10% 
≥15µm 
 
Each particle size standard suspension was diluted with dilution media to a stock concentration 
of approx. 13000 /ml using the following relation: 
Equation 1: suspension based particle concentration  determination 






−+
=
p
p
fp
f
C
D
V
x
ρ
ρ
ρπ
ρ
3
6
 
 
Where x/V represents the particle concentration, ρf the fluid density, ρp the particle density, C 
the suspension’s particle concentration in percent solids and Dp the particle’s mean diameter. The stock 
suspensions (free of foreign particles or particle fragments) were tested by LO and MDI methods to 
assure the particle stock suspensions can be mixed without having particle population overlaps. 
For verification of the small volume LO method, polystyrene size standards with nominal particle 
size of 2, 10 and 25 µm were used whereas each particle standard was diluted with water for injection 
(WFI) to three different concentrations: 260, 360 and 2200 counts per ml for 2 µm particles, 25, 75 and 
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330 counts per ml for 10 µm particles and 5, 20 and 120 counts per ml for the 25 µm particles (termed 
“Polystyrene Particles 1”).  
To compare the limitations of MDI technologies, Polystyrene particle count standards in a range 
of 2, 5, 10, 25 µm with particle concentrations of 2000 ± 200 per ml (termed “Polystyrene Particles 2”) 
were also prepared. 
For assessing sample matrix influence, a mixture of 2, 5 and 10 µm polystyrene size standard 
stock suspensions was compounded containing 4333 particles per ml by calculation for each particle 
population. 
Glass Particles 
Borosilicate glass particle standards were used as powders from Thermo Scientific (Fremont, CA, 
USA) with nominal particle sizes of 2 and 8 µm as summarized in Table 2. 
Table 2: Summary of physical properties of borosili cate glass particle standards  
Cat no 
nominal 
size 
certified 
mean 
diameter 
standard 
deviation 
uncertain
ty mean 
diameter 
microsph
ere 
density 
index of 
refraction 
approximate 
number per 
gram 
 [µm] [µm] [µm] [µm] [g/cm
3
] at 589nm per gram 
9002 2 2.00 0.6 0.4 2.50 1.56 9.5E+10 
9008 8 8.00 1.0 0.4 2.55 1.56 1.5E+09 
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Suspensions of approx. 13000 /ml were obtained by suspending the glass particle powder (C=1) 
with diluent media using the simplified relation: 
Equation 2: powder based particle concentration det ermination 
3
6
p
f
DV
x
π
ρ
=   
Where x/V represents the particle concentration, ρf the fluid density, ρp the particle density, and 
Dp the particle’s mean diameter. A mixture of 2 and 8 µm glass particle stock suspension was 
compounded containing 6500 particles per ml by calculation for each particle population. 
 
“False Protein Standard” 
False protein aggregate standard were obtained from Fluid Imaging Technologies (Fluid Imaging 
Technologies, Maine, USA) with nominal particle concentrations of 5383 /ml ±12% >25 µm, 8818 /ml 
±12% >10 µm (according to vendor information). The sample was re-suspended by gently inverting 20 
times prior to any dilution step. The received material is considered to be under development by the 
supplier,  therefore, stability parameters have not yet been established and further information about 
the manufacturing of the standard was not disclosed. 
 
Colored Suspensions 
A melanoidine containing solution (manufactured internally) was filtered using 0.22 µm 
Stericup-GV Filters (PVDF) membrane type (Millipore, Massachusetts, USA). The stock solution was 
prepared to mimic real life protein formulations: i.e., similar absorption spectra to that of altered or 
degraded protein formulation solutions can be expected. The samples were compounded using dilution 
media to create a target coloration defined by the European Pharmacopeia as B1.
22
 The calculated 
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particle concentration for polystyrene particle containing samples was 1000 counts per ml and the 
population for glass particle containing sample suspensions was 3000 counts per ml.  
Turbid and Viscous Suspensions 
A turbidity standard based on styrene divinyl benzene (SDVB) copolymer beads in the submicron 
range was used to obtain turbid suspensions. NIST traceable AMCO CLEAR Turbidity Standard 1000 FTU 
(GFS Chemicals, Ohio, USA) was filtered sterile using 0.22 µm Stericup-GV Filters (PVDF) membrane type 
(Millipore, Massachusetts, USA) . Viscous suspensions were compounded using analytical grade Glycerol 
(ACROS, Geel, Belgium), filtered through 0.22 µm Stericup-GV Filters (PVDF) membrane type (Millipore, 
Massachusetts, USA).  
Turbid and viscous particle suspensions were compounded by mixing polystyrene, glass and 
“false protein particle” stock suspensions with above solutions to target turbidity values of 15 and 
30 FTU and viscosities of 1, 11 and 20 mPa*s. Due to the change in refractive index, glycerol quenches 
turbidity caused by SDVB submicron particles. Therefore the needed amount of SDVB copolymer beads 
in glycerol-water mixtures was assessed prior compounding (Figure 2) to obtain target turbidity values. 
  
 
 
Figure 2: Turbidity in glycerol/water mixtures: mea sured turbidity vs. theoretical turbidity using 
mixtures of SDVB beads with water ( ) and water/glycerol with a refractive index of 1.4 2 () and 
1.43 (). The slope for water like suspensions is 1.01 whe reas the slopes are 0.66 and 0.61 for 
glycerol/water mixture of 10mPa*s and 20mPa*s, resp ectively. 
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The final particle suspensions theoretically contained 3000 particles per milliliter for polystyrene 
particles, i.e. 1000 particles per milliliter of 2 µm polystyrene size standard, 1000 particles per milliliter 
for 5 µm polystyrene size standard and 1000 particles per milliliter 10 µm polystyrene size standards. 
The final glass bead suspensions theoretically contained 3000 particles per milliliter of the 2 µm glass 
particles and 3000 particles per milliliter  of the 8 µm glass beads (in total 6000 particles per milliliter). 
The “false protein particle standard” theoretically contained particle concentrations of 1345 /ml >25 µm 
and 2204 /ml >10 µm. 
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Analytical Methods 
Turbidity Determination 
Under laminar airflow (LAF) conditions, samples were prepared by transferring the solution into 
washed and sterilized, particle-free 11mm glass cuvettes (Hach Lange GmbH, Düsseldorf, Germany). 
Using a HACH 2100AN turbidimeter (Hach Company, Loveland, CO), the turbidity measurements was 
performed instrumentally as outlined in the EP method 2.2.1.
23
. The instrument was calibrated against 
formazin reference suspensions and thus the results are expressed as formazin turbidity units (FTU). 
Viscosity Measurement 
Samples viscosity was assessed by a MCR300 rheometer (Anton Paar GmbH, Graz, Austria) using 
a plate-cone measurement system (Cone: CP25-0.5 Anton Paar GmbH, Graz, Austria). Measurements 
were performed at 20°C. Sample was equilibrated for one minute at a shear rate of 10-s, then shear rate 
was increased from 100-2000-s within one minute. Finally during the holding step at a shear rate of 
2000-s dynamic viscosity was recorded six times over 15 seconds. The averaged value is the result of a 
single measurement. Measurements were done as duplicates reporting the mean ± absolute deviation. 
Color Determination 
Using a Dr. Lange LICO 200 liquid colorimeter (Hach Company, Loveland, CO), the coloration of 
the samples was determined in 11mm glass cuvettes (Hach Lange GmbH, Düsseldorf, Germany). The 
spectral data of sample absorbance between 380 and 720 nm in 10 nm steps was transformed into Lab-
values which also can be described in European Pharmacopeia (EP) and United States Pharmacopeia 
(USP) color codes.
22
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Absorbance Spectroscopy 
The sample absorbance was determined by measuring UV-visible absorption spectra between 
320 and 840nm on a UV/Vis Spectrometer (Lambda 35, Perkin Elmer, Waltham, Massachusetts, USA) 
using 1cm plastic disposable cuvettes. 
Refractometry 
The refractive indices were collected using a Mettler RE40D digital refractometer at 20°C. 
Light Obscuration 
The sub-visible particle counts were measured using the different light obscuration methods as 
described below. The subvisible particles are detected and their size deduced from the amount of light 
blocked as the particles pass a light beam.  
HIAC/Royco 
The analysis was performed using a HIAC/Royco 3000A Liquid Syringe Sampler (termed HIAC) 
with a HRLD-150 sensor with a 780 nm laser light (max. particle concentration 18,000/ml as per the 
vendor’s information) and the software PharmSpec version 2.0 (HACH Ultra Analytics, Grant’s Pass, OR) 
under laminar air flow (LAF) conditions. Fill and ejection rates were fixed to 10 ml/min. 
For the regular USP/EP method, sample measurement consisted of four injections/aliquots at a 
volume of 5 ml each.
1,3
 For the small sample volume LO method, each sample measurement was 
performed three times at a volume of 0.4 ml, using a modified version to USP/EP method, as described 
previously.
3,24
 The first injection was discarded and the mean value was obtained from the last two 
injections for the small sample volume method compared to the mean value of the last three injections 
was calculated for compendial test methods. 
19 
 
Discarding the first run with 0.4 ml method was not sufficient for the high viscosity samples used 
when assessing the sample matrix influence (Figure 3). Therefore, 4 aliquots of 0.4ml were used per 
sample analysis, whereas the first two were discarded and the mean value was calculated from run 3 
and 4. Between each sample analysis, the system was rinsed with water for injection to the point at 
which the ≥2 µm particle counts of the apparatus were less then 10 to avoid the influence of 
environmental contaminations during the measurements. Sub-visible particle are presented as 
cumulative counts per ml. 
 
Figure 3: Subvisible particle counts ( ≥2 µm) as measured by low volume LO method (0.4 ml 
aliquots) for 2, 5, 10 µm polystyrene beads in diff erent sample matrices: water as reference media 
R(), colored matrix C( ), opalescent matrix T( ), 35 FTU at 11 mPa*s TTV (), 30 FTU at 20 mPa*s 
TTVV (), 16 FTU at 20 mPa*s TVV() and clear at 11 mPa*s V( ). See Table 5 for further 
description of sample matrices. 
Klotz Syringe 670nm and Syringe 780nm 
A different light obscuration system called Syringe (Fa-Klotz, Bad Liebenzell, Germany) was also 
used to perform subvisible particle analysis. Two 230 µm Flow Cells with a LDS23/25 sensors with a 
maximum particle concentration of 100000 /ml were tested. One with a 670 nm laser ligth source 
(termed SY6) and similar to the used HIAC sensor one with  780 nm laser (termed SY7) light. In analogy 
to HIAC measurements, fill and ejection rates were fixed to 10ml/min and each sample measurement 
was performed four times at a volume of 0.4 ml per injections. The first two runs were discarded and 
the mean value was obtained from injection 3 and 4.  Between each sample analysis, the system was 
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rinsed with water for injection to the point at which the ≥ 2 µm particle counts of the apparatus were 
less then 10 to avoid the influence of environmental contaminations during the measurements. 
Microflow Digital Imaging 
MFI 5x 
Sub-visible particles were measured using MFI DPA4100 Flow Microscope Series B (Brightwell 
Industries, Ontario, Canada) under LAF conditions. The instrument can be configured either for a particle 
size range of 0.75 to 100 µm for the 14x magnification or 2 to 400 µm for the 5x magnification. 
Brightfield images of individual particles are captured as a sample stream passes trough a flow-cell 
centered in the field of view illuminated by a blue LED. Images are analyzed by the system software 
(DPA4100 MFI software, version 6.9.7) to extract each particle and compile a database containing 
particle counts and size. Additionally, saved images can be analyzed retrospectively to determine count, 
size and transparency, as well as shape parameters such as area, perimeter, circularity, maximum 
Feret’s diameter (expressed in microns), and aspect ratio (ratio of the minor axis length over the major 
axis length of an ellipse with the second moments of the particle). Transparency is expressed as mean 
object intensity which stands for the average intensity of all pixels representing a particle. These 
intensity levels that are related to 10bit sensor of the digital camera, which provides 1024 illumination 
levels between dark (0) and bright (1023). This property is affected by the difference between refractive 
index of the particle and the background. The circularity of an object is expressed as a value between 0 
and 1 and represents the ratio of the circumferrence of an equivalent spherical diameter (ESD) area over 
the measured perimeter. The samples were drawn under LAF from a 5 ml pipette through the flow-cell 
using a peristaltic pump. Prior to each analysis, WFI was flushed trough the system to provide a clean 
baseline and to optimize the illumination. For each sample, three separate runs of each 0.4 ml were 
analyzed in parallel to the adapted LO method, whereas the first run was discarded and the remaining 
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two were use for calculation. Additionally, one picture per second was captured for the shape analysis 
whereas the pictures of the first run were also discarded. 
For testing the influence of the sample matrix, sub-visible particles were measured using a 
newer MFI instrument: MFI DPA4200 Flow Microscope Series B (Cell Biosciences, Inc., California, USA; 
former: Brightwell Technologirs Inc., Ontario, Canada). The instrument uses a 5 fold optical 
magnification and a 100 µm field of view flowcell. Images of individual particles are captured as a 
sample stream passes trough a flow-cell centered in the field of view illuminated by a blue LED. Images 
were analyzed by the system software (MVSS software, version 1.2) to extract each particle and to 
compile a database containing particle counts and size. A continous flow was obtained using a peristaltic 
pump. Prior to each analysis, the flow cell was cleaned by flushing alternately with WFI and 2-propanol 
and subsequently allowing the system to run dry. A sample volume of 1.2 ml was drawn under LAF using 
a 2.5 ml pipette whereas 0.18 ml sample was used to flush the flowcell and approx. 0.17 ml was used to 
optimize the illumination and substract the flow cell background. For each sample 0.80 ml was analyzed. 
Additionally, approximately three pictures per second were captured and saved for the shape analysis. 
FlowCam 10x 
Subvisible particle counting and shape analysis was also performed using the FlowCam benchtop 
system with a colored camera and 10x magnification (Fluid Imaging Technologies Inc., Maine, USA) and 
the respective system software (VisualSpreadsheet software, version 2.4.10). FlowCam uses a similar 
technology that to the MFI instrument but utiilizes a white LED light source, crops particle images 
automatically and uses a 1ml syringe pump to establish continous and flow. Similar to MFI 
measurements, the system was cleaned flushing alternately with WFI and 2-propanol prior to each 
sample. Of the 1.2ml sample, 0.3 ml were used to flush a 80µm FC80FV field of view flow cell. 
Background substraction was peformed using the first data frames. For each sample 0.8 ml was 
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analyzed. Particle segmentation was performed using a dark threshold of 25. The distance to the nearest 
neighbour was set to 3 microns. FlowCam 10x, auto image frame rate and flash duration were set to 20 
frames per second and 19 microseconds, respectively. 
An overview of key instrument parameters for the subvisible particle counting methods used in 
this work is provided below in Table 3. 
Table 3: Overview of light obscuration (LO) and mic roflow digital imaging (MDI) methods for 
measuring subvisible particles  
 Microflow Digital Imaging (MDI) Light Obscuration (LO) 
  
FlowC
am 
10x 
dpa42
00 MFI 
5x 
dpa41
00 MFI 
5x 
dap41
00 MFI 
14x 
HIAC HIAC HIAC 
Syring
e 
670nm 
Syring
e 
780nm 
Abbrev. FLO MFI MFI 5x 
MFI 
14x 
EP / 
USP
1-3
 
small 
sample 
volum
e 
HIA SY6 SY7 
Optical 
Magnification 
10x 5x 5x 14x N/A N/A N/A N/A N/A 
Light source 
White 
LED 
Blue 
LED 
Blue 
LED 
Blue 
LED 
780nm 
Laser 
780nm 
Laser 
780nm 
Laser 
670nm 
Laser 
780nm 
Laser 
Sample volume 
used prior to 
analysis / Tare 
volume 
0.3 0.35 0.35 0.35 0.1 0.1 0.1 0.1 0.1 
Particle Size 
Range* 
5-
1000µ
m 
1-
70µm 
2.25-
400 
µm 
0.75-
100µm 
1.2-
150µm 
1.2-
150µm 
1.2-
150µm 
1-
50µm 
1-
50µm 
Analyzed 
Sample Volume 
1 x 
0.8ml 
1 x 
0.8ml 
3 x 
0.4ml 
3 x 
0.4ml 
4 x 5ml 
3 x 
0.4ml 
4 x 
0.4ml 
4 x 
0.4ml 
4 x 
0.4ml 
Result=Average 
from aliquot no. 
1 1 2 & 3 2 & 3 
2, 3 
& 4 
2 & 3 3 & 4 3 & 4 3 & 4 
Flow Rate 
0.2 
ml/mi
n 
0.17 
ml/mi
n 
0.2 
ml/mi
n 
0.1 
ml/mi
n 
10 
ml/mi
n 
10 
ml/mi
n 
10 
ml/mi
n 
10 
ml/mi
n 
10 
ml/mi
n 
Approx. 
Sampling 
efficiency 
14% 31% 85% 8% 100% 100% 100% 100% 100% 
Syringe Size 1ml N/A N/A N/A 10ml 10ml 10ml 5ml 5ml 
*according to vendor information N/A – not applicable  
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Results and Discussion 
Small Sample Volume LO Method Verification 
The scope of this first study was to compare a small sample volume method for light obscuration 
to the larger volume compential test. The development of a smaller volume LO method is warranted in 
order to be able to employ a material saving LO method, especially for pharmaceutical dosage form 
development purposes. As an initial step, three different polystyrene particle suspension standards 
(“polystyrene particles 1”) of particle size ranges of 5, 10 and 25 µm at three different concentrations 
were used. The comparison of results from the small sample volume LO method and the compendia 
tests USP <788> and EP 2.9.19 is presented in Figure 4. Counting accuracy data obtained with the 
particle standards with the small volume and compendia methods were quite comparable. The results 
were subjected to a T-test which showed that the small sample volume method was not significantly 
different from the USP/EP method at a confidence level of 99% for all tested determinations.  
As a second part of this study, the small volume LO method was further verified by measuring 
particle counts in actual aged protein solutions – mAb2 and mAb3 (Figure 5). The results for the small 
sample volume method were not statistically different from the EP/USP method at a confidence level of 
99% for mAb3, and comparable for the mAb2, both having been stored for 6 years at 2-8°C. Although in 
the case of the mAb2 experiments, the differences for particles ≥ 10 µm were statistically significant for 
these samples, these difference are not considered of practical relevance due to (1) the low level of 
subvisible particles (33 vs. 48 particles), and (2) given the typical method variability of light obscuration 
observed over time in the analytical laboratories. 
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 2 µm Polystyrene Particles 10 µm Polystyrene Particles 25 µm Polystyrene Particles 
 
Figure 4: Comparison of counting accuracy of USP/EP  and small sample volume LO methods 
using polystyrene standards with a nominal size of 2 µm, 10 µm and 25 µm (polystyrene particles 
1). The error bars represent ± σ of n=6 independent measurements. USP/EP method ( ), small 
sample volume method ( ). 
 
 
 A: mAb2, aged B: mAb3, aged  
  
    
Figure 5: Cumulative particle counts at ≥ 2, 5, 10, 25 and 50 µm as measured by two LO metho ds 
in (A) aged mAb2 formulations and (B) aged mAb3 for mulations. The error bars represent ± σ of 
n=6 independent measurements. USP/EP method ( ), small sample volume method ( ). 
 
  
25 
 
One of the most important experimental parameters for developing a reproducible small sample 
volume LO method is to ensure that the volume of the first aliquot to be measured is sufficiently higher 
than the sum of dead and the mixing phase volumes during sample introduction.  This minimal volume is 
needed to avoid false positive results from being generated during the initial measurement. These 
parameters are dependent on the sample type, for example during the mixing phase, streaking can 
occur which could lead to false positive particle counting 
25
. Therefore, the small sample volume method 
was also tested with a large number of aliquots of 0.4 ml for every sample. These results (Figure 6) 
showed that a pre-dispensed volume of 0.4 ml is sufficient for all measured samples. 
  
 
 
Figure 6: HIAC small sample volume LO method showin g particle counts ≥ 2 µm versus number of 
0.4 ml aliquots for a variety of samples:  polystyr ene particle bead standards in suspension, 2 µm  
(), 10 µm (), and 25 µm ( ), and protein samples containing aged mAb2 ( ) and aged mAb3( ). 
 
In summary, the small volume LO method yields comparable results to the USP/EP LO methods 
in terms of the particles counts at ≥ 2, ≥ 5 µm as well as for the counts for USP/EP ≥ 10, ≥ 25 µm. In 
addition, the small sample volume LO method applied requires only 6% sample volume USP and EP 
defined LO methods. 
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Exploring the Advantages and Limitations of MDI 
Comparison of Light Obscuration and Micro Flow Imaging 
Polystyrene particle bead standards (“polystyrene particles 2”) were used initially to compare 
particle counting accuracy and precision of two different sub-visible particle instruments (MFI and LO). 
Using particle standards with a nominal size of 2, 5, 10 and 25 µm (EZY-CAL NIST polystyrene particle 
size standards Thermo Fisher), the objective of the first study was to compare LO and MFI versus the 
label claimed particle concentration of 2000±200 particles per ml (Figure 7). For 10 and 25 µm particles, 
both MFI (5x magnification) and LO counts were within the expected range and were comparable with 
regards to accuracy and precision. For 5 µm particles, the MFI (5x and 14x magnification) and LO counts 
were within the expected range. However, the precision of the MFI using a high magnification setting 
was poor compared to either the MFI using a low magnification setting or the LO instrument. Low 
sample efficiency implies a lower probability to coincidentally meet the true mean value compared to 
high sample efficiencies. Additionally, with increasing efficiency (meaning increasing probability of 
detecting particles), the confidence interval decreases. It can therefore be stated that assay precision for 
particle counting can be indirectly proportional to sample efficiency which for LO is 100%, for MFI 5x 
magnification 85%, and for MFI 14x magnification only 8%.  
In addition, the MFI counts (5x magnification) were slightly higher than the LO counts which 
might be attributed to the resolution at the lower size range limit. MFI resolution is limited by the 
optical system and the sensor. The sensor provides an image of 1280 x 1024 pixels (1.3 megapixel) which 
corresponds to a field view of 1760 x 1400 µm for MFI 5x magnification and 620 x 500 µm for MFI 14x 
magnification. Consequently, the pixel density of MFI 5x magnification is 1.895 µm/pxl and 0.238 µm/pxl 
for MFI 14x magnification. For 2 µm particles, the MFI counts using the high magnification was slightly 
above the expected range which also could be explained by the resolution, as mentioned above, 
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whereas the LO counts were within the expected range. Using actual protein formulation samples, such 
as a freeze-thaw stressed mAb2 solution, the MFI counts were generally higher compared to the LO 
results for subvisible protein particles up to 25 µm (Figure 9 and Figure 10). This result has also been 
reported previously for other proteins although the discrepancy was not as pronounced.
6
 Surprisingly, 
MFI 5x counts in the particle size range of 2.25 to 3 µm were substantially higher than MFI 14x counts 
for well-defined polystyrene particles and protein samples (Figure 8 and Figure 10), respectively. These 
subvisible particle counting discrepancies at low size ranges for proteinaceous particles may be 
explained by how the particles are recognized by the different technologies. MFI software computes 
whether a pixel is “particle” or “not particle” based upon a defined threshold value for the difference of 
background pixel value subtracted from incoming value of the same pixel. For particles with sizes of a 
single pixel, static intensity irregularities resulting from the light source, the sample liquid, the flow cell 
or the magnification system could cause false counting and ghost particles. In addition, software caused 
particle fragmentation may lead to significantly higher particle counts in the 2µm size range, but only 
affect particle counts in larger particle size regions to a minor extent. 
It has been hypothesized and confirmed experimentally in the literature that the LO method 
may have difficulties in counting translucent subvisible particles since light is only partially blocked by 
translucent particles (such as glass or proteinaceous particles) as compared to polystyrene particle of 
the same size which are not translucent in nature. Therefore, the LO technique may under count and/or 
recognize translucent particles as smaller in size than they are in reality. Reasons for counting 
discrepancies between MFI and LO hypothesized in the literature include differences in the translucence 
and circularity of protein particles in comparison to polystyrene standards
6
.  
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 Polystyrene particles 
 
 
Figure 7: Particle counting accuracy of LO (HIAC, ), MFI 5x magnification ( ) and MFI 14x 
magnification ( ) for polystyrene particle bead standards. Particle  counts are within the specified 
limitations of the polystyrene counting samples. Th e error bars represent ± σ of n=3 independent 
measurements 
 
 
 Polystyrene particles 
 
 
Figure 8: Particle counting accuracy of LO (HIAC, ), MFI 5x magnification ( ) and MFI 14x 
magnification ( ) for polystyrene particle bead standards. Distribu tion of 2 and 5 µm polystyrene 
beads with resolution by particle size. The error b ars represent ± σ of n=3 independent 
measurements. 
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 Freeze-thaw stressed mAb2 
 
 
Figure 9: Particle counting of freeze-thaw stressed  mAb2 samples as measured by LO (HIAC, ), 
MFI 5x magnification ( ) and MFI 14x magnification ( ). Cumulative particle counts with standard 
bins. The error bars represent ± σ of n=3 independent measurements 
 
 
 Freeze-thaw stressed mAb2 
 
 
Figure 10: Particle counting of freeze-thaw stresse d mAb2 samples as measured by LO (HIAC, ), 
MFI 5x magnification ( ) and MFI 14x magnification ( ). Distributive and cumulative particle 
counts below 10µm.The error bars represent ± σ of n=3 independent measurements.  
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Comparison of Micro Flow Imaging (MFI) and FlowCam 
Particle shape and morphology were evaluated with the MFI (5X and 14X) and FlowCam (10X) 
instruments for a variety of subvisible particles including polystyrene bead standards, silicone oil 
droplets, aged and stressed protein samples, and polysorbate related particles.  FlowCam 10x pictures 
were generally of better quality than MFI 5x and even MFI 14x pictures.  The captured images of the 
different types of subvisible particles support the results and conclusions drawn from the shape analyses 
below (Table 4). 
As shown in Figure 11, the results for the chosen shape parameters were dependent on the 
particle size range for both MFI 5x and FlowCam 10x. The FlowCam 10x instrument showed higher 
variability than the MFI 5x instrument with regards to mean object intensity and circularity, presumably 
due to a different depth of field (Figure 11). For particles < 10 µm, the MFI at 5x magnification could not 
distinguish between the particle types analyzed, namely polystyrene particles, silicone oil droplets, 
proteinaceous particles or polysorbate related particles (Figure 11). Using the shape parameter “mean 
intensity”, MFI 5x could only reliably distinguish between silicone oil droplets and proteinaceous sub-
visible particles for particle sizes > 10 µm, although the differences detected were rather marginal. In 
fact, the circularity of silicone oil droplets and proteinaceous sub-visible particles were not significantly 
different. Using the shape parameter “circularity”, FlowCam 10x could clearly separate silicone oil 
droplets from proteinaceous sub-visible particles for particle sizes > 5 µm (Figure 11). On the other 
hand, proteinaceous particles could not be distinguished from excipient-related particles using the 
single shape parameters “mean intensity” and/or “circularity” (Figure 11). Because MFI 14x has low 
sampling efficacy, fewer data points could be calculated. High standard deviations were obtained due to 
blurred images resulting from a combination of low depth of field and the large depth of the flow cell for 
the MFI 14x instrument.   
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Previous reports have confirmed differences using MFI mean object intensity (surrogate for 
translucency) of protein particles versus polystyrene standards for particles sizes ≥ 5 µm (as shown in 
Figure 11).
6
 However, MFI circularity measured was not significantly different for all particle sizes 
observed. Thus, for particle sizes ≥ 5 µm, the reason for counting differences between MFI and LO may 
be the difference in translucency for protein particles, but not necessarily due to a difference in the 
measured circularity. The translucency measured of 2 µm protein particles was similar, however, to the 
translucency of polystyrene standards of similar size (Figure 11). Thus, the reason for the obsereved 
counting differences between MFI and LO for particles in the range of 2 to 5 µm cannot be solely 
attributed to the apparent differences in the translucent nature of protein particles. The translucency 
and circularity of polysorbate 20 related particles was measured similar to polystyrene standard for 
particle size ≤ 15 µm (Figure 11). Nevertheless, the MFI counts were significantly higher for particles ≥ 2 
and ≥ 5 µm. Thus, translucency and circularity cannot be the (sole) reason for counting differences 
between MFI and LO. 
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 FlowCam 10x MFI 5x MFI 14x 
A 
B 
C 
 
Figure 11: Particle shape as measured by FlowCam an d MFI analyzed by instrument software: (A) 
Circularity, (B) Mean Intensity and (C) Aspect rati o. Polystyrene particle standards 2 [EZY CAL 2, 5 
10, 25um] (), silicone oil droplets mAb4 placebo ( ), freeze-thaw stressed mAb2 ( ), aged 
mAb1 (), polysorbate related particles mAb3 ( ). The error bars represent ± σ of ≥ 20 
representative particles. 
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An “aspect ratio” particle analysis for MFI 5x was described previously in literature to effectively 
isolate silicone oil droplets greater than 5 µm in size.
25,26
  The published data analysis approach of using 
a “silicone oil filter of ≥0.85 aspect ratio” was applied to the different particle populations evaluated in 
this work (Figure 12).  In Figure 12, the total number of particle counts of the individual population was 
normalized to 100%, and the shaded parts represent particles with an aspect ratio ≥0.85. In general, 
particle counts increased with decreasing particle size implying the data analysis filter was neither 
applied nor suited for 40 to 85 % of the particles detected. Within the size range of 5 to 10 µm, the data 
analysis filter isolated 98% of the silicone oil droplets yet only 13 % of its whole population. When the 
data analysis filter was applied to proteinaceous particles within the same size range, a misclassification 
of 18 % (mAb1) and 26 % (mAb2) was observed, respectively. At higher size ranges, the particle numbers 
are in general too low to draw utilizable conclusions for the total particle population.  
  
 
  
 
 
Figure 12: A “silicone oil filter” to analyze the a spect ratio of various particle samples as a 
function of different particle size populations as measured by MFI 5x. The total number of 
particles for each sample was normalized to 100%. T he dashed bars represent the fraction of 
particles which show aspect ratio values >=0.85, th e solid bars represent the fraction of particles 
with aspect ratio values of <0.85.  Samples include  Polystyrene particle standards 2 [EZY CAL 2, 5 
10, 25um] (), silicone oil droplets mAb4 placebo ( ), freeze-thaw stressed mAb2 ( ), aged mAb1 
(), polysorbate related particles mAb3 ( ). 
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Table 4: Representative images of different subvisi ble particles as measured by MFI and FlowCam 
 FlowCam 10x MFI 5x MFI 14x 
Polystyrene size standards  
3µm 
 
2µm 
 
2µm 
 
4µm 
 
5µm  
5µm 
 
10µm 
 
10µm  
10µm 
 
26µm 
 
25µm 
No adequate picture 
captured 
Silicone Oil Droplets  
3µm 
 
2µm 
 
2µm 
 
5µm 
 
5µm  
6µm 
 
12µm 
 
10µm  
10µm 
 
26µm 
 
26µm 
 
19µm 
Excipient related particles 
 
3µm 
 
2µm 
 
2µm 
 
6µm 
 
6µm 
 
6µm 
 
12µm 
 
11µm  
12µm 
 
 
25µm 
 
20µm 
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 FlowCam 10x MFI 5x MFI 14x 
Proteinaceous particles 
(mAb1) 
 
3µm 
 
2µm 
 
2µm 
 
5µm 
 
5µm  
6µm 
 
11µm 
 
10µm  
11µm 
 
25µm 
 
26µm  
21µm 
Proteinaceous particles 
(mAb2) 
 
3µm 
 
2µm 
 
2µm 
 
5µm 
 
5µm  
5µm 
 
11µm 
 
10µm  
11µm 
 
26µm 
 
25µm 
 
18µm 
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Sample Matrix Influence 
Determination of Sample Properties 
Prior to the analysis of different subvisible particulates in solutions with varying physcial 
properties, samples were first analyzed and catorgoriezed in terms of their different solution properties 
by assessing color, turbidity, viscosity, refractive index and their UV-absorption spectrum. Different 
solutions were prepared with different physical properties and in general they showed the expected 
variety of physical properties (Table 5 and Figure 13). However, it is worth noting that turbidity had a 
significant impact on the color determination. Due to high turbidity levels, the solution appeared darker 
and consequently was attributed to best match a slightly different color standard (Table 5).  
Table 5: Physical properties of different sample su spensions including the water reference, 
colored, turbid and viscous solutions. 
 
Abbrev. Color
22,27
 Refractive Index Viscosity Turbidity
23
 
  
 Index [mPa*s] [FTU] 
Water Reference Suspension R B9 1.3346±0.00095 1.0±0.0 0.0±0.1 
Colored Suspension C B1 1.3345±0.00087 1.0±0.0 0.9±0.1 
Opalescent  Suspension T B6 1.3346±0.00089 1.0±0.0 51.1±0.9 
Viscosity level II /opalescence 
level I suspension 
TVV B7 1.4262±0.00020 20.2±0.2 16.2±1.2 
Viscosity level II /opalescence 
level II suspension 
TTVV B6 1.4262±0.00000 20.2±0.1 31.3±1.4 
Viscosity level I /opalescence 
level II suspension 
TTV B6 1.4189±0.00632 11.7±0.1 34.2±0.5  
Viscous suspension V B9 1.4190±0.00581 11.0±0.1 1.0±0.3 
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A Sample absorbance spectra 
 
B Sensor emission spectra 
 
Figure 13: (A) UV Absorption spectra for particle f ree sample matrices including water as 
reference media R( ), colored matrix C( ), opalescent matrix T( ), 35 FTU at 11 mPa*s TTV (), 30 
FTU at 20 mPa*s TTVV (), 16 FTU at 20 mPa*s TVV() and clear at 11 mPa*s V( ). See Table 5 for 
further description of sample matrices. (B) normali zed Emission spectra of the individual 
instruments: blue LED of MFI ( ), FlowCam’s white LED ( ), the 780 nm laser of HIAC and Syringe 
with 780 nm laser( ) and Syringe with 670 nm laser ( ).  
 
Particle Sizing 
Although often ignored in practice, common statistical descriptors and tests used in analytical 
analyses typically require normal distributed data. For the particle counting and sizing studies described 
below, Skewness and Kurtosis were used to measure departures from normality.
28,29
 Skewness and 
Kurtosis of all populations except “false protein standard” were within acceptable range in order to have 
minimal error using statistical descriptors and tests (e.g. SD, ANOVA, F-test, t-test) designed for 
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distributions similar to normal. Therefore “false protein standard” populations could not be statistically 
analyzed by t- and f-tests for assessing sizing accuracy and precision. 
Sizing Accuracy 
The population mean particle size values in the various solutions with different physical 
properties were compared to the mean particle size obtained from the reference suspensions by each of 
the different individual instruments evaluated. All instruments recognized the 2 µm polystyrene 
particles as smaller as the nominal values provided by the supplier (Figure 14). Results from the 
individual methods and solutions differed from one and another. In contrast, the 2 µm borosilicate glass 
particles in water-like fluid were sized within the range provided in the supplier’s certificate (2.0±0.4µm) 
for all instruments (Figure 15).  The FlowCam instrument shows a very wide distribution compared to 
other techniques, probably due to the depth of the flow cell leading to particle images being out of 
focus. Due to this high uncertainty, the effect of the sample matrix seems to play a minor role and can 
only be seen for matrices with higher refractive indexes (Figure 14). MFI shows very narrow distributions 
for polystyrene particles, although larger particles (10 µm) are affected by viscosity, and solution 
population size is lowered by smaller differences in refractive index, respectively. In addition, LO seems 
to be solely influenced by changes in RI which is not consistent to results comparing HIAC undersizing of 
5 µm polystyrene while the Syringe 780 nm recognizes these particles as larger than in water like media 
(Figure 14). Interestingly, the particles seem to not be affected by turbid or colored sample matrices 
(Figure 14 and Figure 15). The 8 µm glass spheres are oversized in viscous media using MFI, FlowCam 
and Syringe 670nm laser whereas the LO instruments with 780nm laser (Syringe 780 and HIAC) show no 
effect (Figure 15). The emitted wavelength seems to play a role when looking at translucent particles. 
Most interesting are the findings for the “false protein standard”: practically all LO instruments shifted 
the populations to smaller size ranges when using media of higher refractive index (Figure 15).  
39 
 
In the second part of this evaluation, the influence of different samples were elucidated by performing a 
one-tailed t-test with a hypothesized mean difference between two independent populations of zero, 
i.e. the obtained mean particle size of the respective reference suspension compared to the apparent 
sizes of the same samples in solutions with different physical properties.  The effect sizes (d) for 
differences from 0.25 µm to 1.25 µm with a step size of 0.5 µm were defined (Table 6) and termed as 
follows: difference of 0.25 µm is termed “very small”, ±0.50 µm “small”, ±0.75 µm “medium”, ±1.00 µm 
“large” and ±1.25 µm termed “very large”. The effect size (Cohen's d) is defined as the difference 
between two means divided by a standard deviation for the data. Having different standard deviations 
the effect sizes for these absolute differences are varying per particle population and instrument used 
(Table 6). A priori Type I error rate (α), also termed “false positive”, was set to 0.05 prior to analysis and 
power (1-β) was set to 0.80. Keeping α and 1-β constant leads  to individual effect sizes (d, Table 6) per 
particle type and instrument, corresponding individual sample sizes (ni, Table 7) (which is identical with 
the number of individual particles) and critical values of a t-distribution (tcrit). For each test, the particles 
of the individual populations were selected by the proportional scaling down of their distributions until 
the desired sampling size (ni) was obtained. 
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Table 6: effect sizes attributed to absolute mean d ifferences between particle populations in 
reference suspensions and suspensions with … 
 
 
Effect size d 
 
 
∆M= 
0.25µm 
∆M= 
0.50µm 
∆M= 
0.75µm 
∆M= 
1.00µm 
∆M= 
1.25µm 
F
lo
w
C
a
m
 1
0
x
 2µm Polystyrene beads 0.45 0.90 1.35 1.80 2.25 
5µm Polystyrene beads 0.30 0.60 0.90 1.19 1.49 
10µm Polystyrene beads 0.15 0.31 0.45 0.64 0.76 
2µm glass spheres 0.28 0.56 0.84 1.11 1.39 
8µm glass spheres 0.14 0.29 0.43 0.58 0.72 
M
F
I 
5
x
 
2µm Polystyrene beads 0.48 0.96 1.44 1.92 2.40 
5µm Polystyrene beads 0.56 1.11 1.67 2.22 2.78 
10µm Polystyrene beads 0.43 0.85 1.28 1.70 2.13 
2µm glass spheres 0.38 0.76 1.14 1.52 1.90 
8µm glass spheres 0.22 0.43 0.65 0.86 1.08 
H
IA
C
 
2µm Polystyrene beads 0.75 1.49 2.24 2.98 3.73 
5µm Polystyrene beads 0.27 0.54 0.81 1.08 1.34 
10µm Polystyrene beads 0.27 0.54 0.81 1.09 1.36 
2µm glass spheres 0.28 0.57 0.85 1.14 1.42 
8µm glass spheres 0.20 0.40 0.59 0.79 0.99 
S
y
ri
n
g
e
 6
7
0
 n
m
 
2µm Polystyrene beads 0.48 0.95 1.43 1.91 2.38 
5µm Polystyrene beads 0.71 1.41 2.12 2.83 3.54 
10µm Polystyrene beads 0.65 1.31 1.96 2.61 3.26 
2µm glass spheres 0.29 0.57 0.86 1.15 1.43 
8µm glass spheres 0.24 0.48 0.72 0.96 1.96 
S
y
ri
n
g
e
 7
8
0
 n
m
 
2µm Polystyrene beads 0.65 1.30 1.96 2.61 3.26 
5µm Polystyrene beads 0.71 1.43 2.14 2.85 3.56 
10µm Polystyrene beads 0.92 1.83 2.75 3.66 4.58 
2µm glass spheres 0.27 0.55 0.82 1.09 1.37 
8µm glass spheres 0.20 0.40 0.61 0.81 1.01 
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Table 7: sample sizes (n i) corresponding to the effect sizes in Table 6. 
 
 
sample size ni 
 
 
∆M= 
0.25µm 
∆M= 
0.50µm 
∆M= 
0.75µm 
∆M= 
1.00µm 
∆M= 
1.25µm 
F
lo
w
C
a
m
 1
0
x
 2µm Polystyrene beads 124 32 16 10 8 
5µm Polystyrene beads 280 72 34 20 14 
10µm Polystyrene beads 1086 256 122 62 46 
2µm glass spheres 322 82 38 22 16 
8µm glass spheres 1180 296 134 76 50 
M
F
I 
5
x
 
2µm Polystyrene beads 110 30 14 10 8 
5µm Polystyrene beads 82 22 12 8 6 
10µm Polystyrene beads 140 36 18 12 8 
2µm glass spheres 174 46 22 14 10 
8µm glass spheres 532 134 62 36 24 
H
IA
C
 
2µm Polystyrene beads 46 14 8 6 5 
5µm Polystyrene beads 342 88 40 24 16 
10µm Polystyrene beads 338 86 40 24 16 
2µm glass spheres 310 80 36 22 14 
8µm glass spheres 632 160 72 42 28 
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2µm Polystyrene beads 112 30 14 10 8 
5µm Polystyrene beads 52 14 8 7 6 
10µm Polystyrene beads 60 18 10 7 6 
2µm glass spheres 304 78 36 22 14 
8µm glass spheres 434 110 50 30 10 
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y
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2µm Polystyrene beads 60 18 10 6 5 
5µm Polystyrene beads 52 14 8 7 6 
10µm Polystyrene beads 32 10 6 5 4 
2µm glass spheres 332 84 40 24 16 
8µm glass spheres 608 154 70 40 26 
 
Generally, there were only minor sizing effects observed with polystyrene particle bead 
standards in the different solutions as measured by the different instruments (Table 9 and Figure 14).   
More differences in sizing effects were seen when evaluating translucent glass particles (Table 9, Table 8 
and Figure 15). This result is probably due to the fact that most of the interaction with light is adsorption 
and reflection for polystyrene particles. The fraction of light being refracted is larger for glass particles 
and therefore changes in refraction index influenced the particle sizing. 
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With regards to the 8µm glass spheres, LO by HIAC (HIA) was underestimating particle size 
values in viscous media, whereas all other methods showed either only marginal effects (e.g., Syringe 
with 780nm laser, SY7) or recognized the particles as larger when decreasing the difference of refractive 
index. HIAC maeasurements also underestimated 5 and 10µm polystyrene particles with increasing 
solution viscosity, as well as decreasing refractive index of media and particles, respectively (Table 9 and 
Figure 14). 
Given that the 2 µm particles are at the very edge of detection (for MDI and LO methodologies 
due to Abbe Limit), one can observe the appearance of airy discs that is significantly changing with 
decreasing differences in refractive index (Table 8). As these analytical systems are typically calibrated 
using particles that highly differ in refractive index from the fluid – namely polystyrene in water – this 
effect is likely leading to large sizing effects. The effect is rather marginal, however, when varying the 
emitting wavelength of the instrument (LO with 670nm Laser (SY6) vs. LO with 780nm laser (SY7)). 
Table 8: Visualization of calculated differences in  refraction and diffraction properties for 
translucent glass particles in water (R) and a glyc erol/water mixture (V).  See Table 5 for further 
description of sample matrices. 
Matrix refraction for 8 µm glass sphere 
Diffraction for a 2 µm glas 
sphere at 780 nm (airy 
discs) 
R 
 
 
V 
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MDI methods did not show large variations in sizing except for MFI 8, 10 µm glass particles 
which were recognized as 0.7 µm smaller than in the reference suspension (Table 9 and Figure 15).  
LO methods showed large variations in sizing (0.3-0.5 µm difference) for 5 and 10 µm 
polystyrene bead particles whereas solution viscosity caused the most significant difference. However, 
this finding could not be well-correlated to the decrease in difference in refractive index of solution or 
particles, for example, glass particles with a Ri = 1.56 were less affected than polystyrene particles 
(Ri = 1.59). In addition, the matrices containing more glycerol did not largely differ in refractive index 
(Table 9 and Figure 14).  
The effect of solution viscosity on MFI measurements of small glass particles was observed and 
is likely attributed to the refractive index. Small differences in sizing were observed for all particle types 
and particle sizes except for 2 µm glass particles recognized by instruments having a 780 nm laser. These 
sizing differences, however, were marginal (Table 9 and Figure 15) and potentially not of practical 
relevance. In contrast to reports in literature, no medium effects or large differences in particle sizing 
were observed for LO methods analyzing glass beads in viscous media, and media of similar refractive 
index, respectively.
30
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 2 µm polystyrene spheres 5 µm polystyrene spheres 10 µm polystyrene spheres 
A 
     particle size [µm]  
B 
     particle size [µm]  
C 
     particle size [µm]  
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2 µm polystyrene spheres 5 µm polystyrene spheres 10 µm polystyrene spheres 
D 
     particle size [µm]  
E 
     particle size [µm]  
Figure 14: Particle size analysis of polystyrene be ad standards in solutions with different physical 
properties as measured by A) FLowCam, B) MFI, C) HI AC, D) Syringe with 670 nm Laser and E) 
Syringe with 780 nm Laser.  Samples include water r eference(R), colored matrix (C), opalescent 
matrix  with 50 FTU (T), 35 FTU at 11 mPa*s (TTV), 30 FTU at 20m Pa*s (TTVV), 16 FTU at 20mPa*s 
(TVV) and clear at 11m Pa*s (V). Analysis of partic le populations presented by box-plot with 
n=10000 per boxplot. The left whisker points to the  population’s minimum (min) whereas the right 
whisker shows its maximum (max) value. The box repr esents the middle 50% of the population 
whereas it is vertically broken by a black line at the population’s median (Mdn). The marker 
represents the populations mean (M). The vertical r ed line represents the particle population’s 
mean size value according to supplier’s information .   
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 2 µm borosilcate glass 8 µm borosilcate glass “false protein standard” 
A 
     particle size [µm]  
B 
     particle size [µm]  
C 
     particle size [µm]  
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 2 µm borosilcate glass 8 µm borosilcate glass “false protein standard” 
D 
     particle size [µm]  
E 
     particle size [µm]  
Figure 15: Particle size analysis of glass bead sta ndards and a false protein standard in solutions 
as measured by A) FLowCam, B) MFI, C) HIAC, D) Syri nge with 670nm Laser and E) Syringe with 
780nm Laser.  Samples include water based reference  (R), colored matrix (C), opalescent matrix  
with 50 FTU (T), 35 FTU at 11 mPa*s (TTV), 30 FTU a t 20 mPa*s (TTVV), 16 FTU at 20 mPa*s (TVV) 
and clear at 11 mPa*s (V).  Analysis of particle po pulations presented by box-plot with n=10000 
per boxplot. The left whisker points to the populat ion’s minimum (min) whereas the right whisker 
shows its maximum (max) value. The box represents t he middle 50% of the population whereas it 
is vertically broken by a black line at the populat ion’s median (Mdn). The marker represents the 
populations mean (M). The vertical red line represe nts the population’s mean of according to 
supplier’s information. 
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Table 9: The statistical significance of measured p article populations in different solution matrices 
was addressed using the one sided t-test with a hyp othesized mean difference of zero as a 
function of different particle sizes. Values in tab le show the smallest sizing effect which was 
significant for different solution matrices in comp arison to the water-reference standard.  
Differences with respective to the water-reference suspensions (R) are shown for each sample 
matrix as a function of particle size in µm (values  greater zero show a significant shift to larger 
particle sizes, negative values to smaller sizes, z eros represent no significant difference color 
code: ).  See Table 5 for further description of sa mple matrices. 
Method Sample Polystyrene particles Borosilicate glass spheres 
 Matrix 2µm 5µm 10µm 2µm 8µm 
FLO C 0.25 -0.25 0 0 0 
T 0.25 0 0.25 0 0 
TTV -0.25 0 -0.25 0 1.25 
TTVV 0 1.25 -0.25 0 1.25 
TVV 0 0 -1.25 -0.75 0.25 
V 0.75 -0.25 -0.75 0 0.25 
MFI C 0.75 0 0 0 0 
T 0 0 0 0 0 
TTV 0 0 0 0 1 
TTVV 0.25 0 0 0 0.75 
TVV 0 0 0 0 0.75 
V 0.75 0 0 0.25 -0.25 
HIA C 0 0 0 0 0 
T 0 0 0 0 0 
TTV 0 -0.75 0 0 0 
TTVV 0 -0.75 -1.25 0 -0.25 
TVV 0 -1.25 -1.25 0 -1.25 
V 0 -0.75 0 0 -1 
SY6 C 0 0 0 0 0 
T 0 0 0 0 -0.25 
TTV 0 0 0 -0.25 0.75 
TTVV 0 0 0.25 -0.25 0.75 
TVV 0 0 0.25 0 0.75 
V 1.25 -0.25 0 0 -0.25 
SY7 C 0 0 0 -0.75 -0.25 
T 0 0 0 -0.75 -0.25 
TTV 0 0 0 -0.75 0 
TTVV -0.25 0.25 0 -0.75 0 
TVV -0.25 0.25 0 -0.75 0 
V 0 0 0 -0.75 -0.75 
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Sizing Precision 
In terms of sizing precision, a coefficient of variance which is only attributed to the individual 
instruments response was applied. This CVi is defined as the square root of the difference of the 
observed sizing variance (sdobs
2
) and the particle variance reported by the supplier (sdp
2
)
 
divided by the 
particle diameter (Dp) as certified by the supplier.
31,32
 Within context of the USP <788> and EP 
pharmacopeia tests, this index is solely attributed to the instruments response and also termed “sensor 
resolution”.
1-3
  
Equation 3: coefficient of variance attributed to i nstruments response (“sensor resolution”) 
 =
	
 − 
  
 
In order to pass the test for sensor resolution according to EP and USP, the CVi has to be lower 
than 0.1 for narrowly distributed, well-defined particles such as 10 µm polystyrene particle size 
standards. LO instruments with a noise level meeting the <0.1 resolution requirement are also stated as 
showing acceptable counting agreement.
26
 
An overview of the obtained sensor resolutions is shown in Figure 16 and Figure 17 for MDI and 
LO methods, respectively. In general, the resolution of 2 µm particles was low. This observation was 
potentially due to the diffraction in LO sensors and the small pixel number and brightness in MDI 
sensors.  
For the FlowCam (FLO) instrument, sensor resolution was in general low and decreased up to 
53% for 2 µm glass particles when using solution matrices with combined turbid and viscous properties 
(Figure 16). Sensor resolution did not change significantly using MFI and polystyrene particles (except for 
2 µm polystyrene beads), but showed significant decrease for 2 µm glass particles (up to 30% lower 
resolution for refractive indices of 1.42, 1.43 respectively). In contrast, the effect of lowering the sensor 
50 
 
resolution on results from the LO methods (especially for the 670 nm sensor) was rather marginal for 
larger particles, but more significant for the smaller 2 µm populations (Figure 17). 
For the LO methods, the syringe sensors instrument showed a better resolution compared to 
the HIAC/Royco (HIA), and precision results stayed below 10% for 10 µm polystyrene standards as 
shown in Figure 17. With regards to glass particles, the 670 nm laser (SY6) showed marginally better 
results for reference suspensions whereas the 780 nm laser (SY7) was less influenced by the sample fluid 
when evaluating glass particle suspensions.  The balancing of these pro and cons is required for a 
decision in terms of selecting one of the two laser wavelengths for measuring particle sizes by a LO 
method. 
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 polystyrene spheres borosilicate glass spheres 
A 
B 
 
Figure 16: Sensor resolution for polystyrene and bo rosilicate glass particle bead standards in 
different solutions using different MDI instruments : (A) FlowCam (FLO), (B) MFI dpa4200 (MFI). 
Samples matrcies include water as reference media R (), colored matrix C( ), opalescent matrix 
T(), 35 FTU at 11 mPa*s TTV (), 30 FTU at 20 mPa*s TTVV ( ), 16 FTU at 20 mPa*s TVV() and 
clear at 11 mPa*s V( ).The horizontal red lines represent 10% sensor res olution. See Table 5 for 
further description of sample matrices. 
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 polystyrene spheres borosilicate glass spheres 
A 
B 
C 
 
Figure 17: Sensor resolution for polystyrene and bo rosilicate glass particle bead standards in 
different solutions using different LO instruments:  (A) HIAC (HIA), (B) Syringe with 670 nm laser 
(SY6), (C) Syringe with 780 nm laser (SY7).  Sample  matrices included water as reference media 
R(), colored matrix C( ), opalescent matrix T( ), 35 FTU at 11 mPa*s TTV (), 30 FTU at 20 mPa*s 
TTVV (), 16 FTU at 20 mPa*s TVV() and clear at 11 mPa*s V( ).The horizontal red lines 
represent 10% sensor resolution. See Table 5 for fu rther description of sample matrices. 
 
 
53 
 
Counting Ability 
Counting Accuracy 
For each instrument and individual particle samples in different solutions, four independent 
repetitions were performed. Special attention was given to sample handling and homogenization in 
order to obtain reliable and reproducible results. Prior to analysis, each sample was gently inverted 20 
times. During these experiments, sinking velocity was observed during pre-tests (data not shown) with 
large glass particles resulting in not being able to these particles. Contamination was minimized by 
working in clean environments and by opening sample containers only at the time of sample injection. It 
should be pointed out, however, for a statistical evaluation with sufficiently high power and error 
probabilities, more repetitions per sample would be needed. The following results are therefore 
presented conventionally and the conclusions drawn should be more seen as indicating trends and 
correlations. 
A couple of additional comments are warranted prior to presenting the data in Figures 18, 19, 
and 20. First, the LO methods using reference suspensions showed higher counts for glass particles. This 
was attributed to low flow speed in MDI methods and high sink velocities of glass particles. The 
reference counts in LO are therefore considered more reliable and also closer to the expected values 
(Figure 18). Second, the particle counts for polystyrene and glass particles shown below (Figure 19 and 
Figure 20, 1
st
 and 2
nd
 column) are reported as greater or equal to a specified particle size when particle 
counting efficiency reaches 100%. Third, due the actual size distribution for the “False Protein 
Standard”, which is much broader than the particle sensors range, particle counts for sizes ≥ 2 µm, 
≥ 5 µm, ≥ 10 µm and ≥ 25 µm are reported (Figure 19, 3rd column). The first of these particle size ranges 
is at the very limit of the sensor, and are reported for information only, whereas the latter two size 
channels are required by EP and USP.1-3  
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With regard to the polystyrene reference suspensions (Figure 18A), the FlowCam method 
showed higher particle counts for all of the polystyrene bead particle sizes examined, whereas the MFI, 
Syringe 670nm (SY6) and Syringe 780nm (SY7) instruments were within the expected range. 
Interestingly, HIAC particle counts for 5 and 10 µm polystyrene particles were less than the calculated 
values. Although the 2 µm glass particles (Figure 18B) were recognized by the LO methods, the observed 
particle counts did not correspond well to the calculated level.  This lack of recognition could be 
attributed to the particle’s translucence combined with the relatively broad size distribution of the glass 
particles.  The translucence of the particle would lead to an underestimation of particle size, and 
consequently, part of the particle distribution might not be not recognized accurately. The expected 2, 8 
and 10 µm glass particle counts by the MDI methods were also not achieved, which is potentially due to 
the slow flow speed and the high density of the glass particles. In terms of analyzing the “false protein 
standards” (Figure 18C), MDI showed significantly higher particle counts than the LO methods for 
smaller size ranges, which is potentially due to fragmentation artifacts of larger particles and/or 
potentially inhomogeneous sample illumination. There were less counting differences observed for 
larger particles between MDI and LO. These discrepancies can be attributed to their high translucence 
and/or the slight underestimation of MDI methods if digital fragmentation on larger particles occurs.  
Figure 19 and Figure 20 show counting accuracy for MFI and LO instruments, respectively. 
Colored or turbid suspensions did not significantly affect counting of polystyrene or glass particles 
(Figure 19 and Figure 20). The influence of viscous suspensions and combinations of turbid and viscous 
suspensions to the counting accuracy was, however, significant yet it did not consistently follow a simple 
relationship: e.g., the FlowCam showed higher counts for glass and polystyrene particles (especially for 
smaller particles not larger than 5 µm) in solutions with 35FTU at  11mPa*s and 16 FTU at 20 mPa*s, but 
not in solutions with 30 FTU at 20mPa*s or clear solutions at 11mPa*s (Figure 19). MFI measurements 
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simply counted less particles when the difference in refractive index of particles and solutions was 
decreased (Figure 19). 
Similar to FlowCam, the HIAC method showed significantly more particles in solutions with 
35FTU at 11mPa*s and 16 FTU at 20 mPa*s for all tested particles (Figure 20 and Figure 19). The Syringe 
670nm was comparable to the Syringe 780nm when measuring polystyrene particles, but showed higher 
counts for glass beads and “false protein standard” (Figure 20). This result of higher sensitivity for 
measuring translucent particles using a smaller emission wavelength LO instrument is consistent with 
results observed with the FlowCam (white LED) and MFI (blue LED) instruments. Yet LO instrument was 
more affected by the refractive index of the sample matrix with regards to precision being less robust 
(Figure 20). Thus, a lower wavelength instrument seems to be more sensitive to measuring the size of 
translucent particles, and therefore, instrument design and detector type both likely play a major role in 
terms of particle counting as we can see when comparing HIAC, Syringe 670 and Syringe 780 (Figure 20). 
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A Polystyrene particles reference suspensions 
 
 
B Borosilicate glass spheres reference suspension 
 
 
C “false protein standard” reference suspensions 
 
 
Figure 18: Particle counts of reference suspensions  of (A) polystyrene particles, (B) borosilicate 
glass spheres, and (C) “false protein standard” usi ng MDI including FlowCam ( ), MFI (), and LO 
including HIAC( ), Syringe 670 nm laser ( ) and Syringe 780 nm laser ( ). The horizontal red lines 
in A and B represent the calculated values and the black horizontal lines are ±10% of the expected 
value. The error bars represent ±sd of n=4 independ ent measurements.  
 
 
57 
 
 
 polystyrene spheres borosilicate glass spheres “false protein particles” 
A 
B 
Figure 19: Particle counts for polystyrene particle  bead standards (1st column), borosilicate glass 
particle bead standards (2nd column) and “false pro tein standards” (3rd column) using MDI 
instruments (A) FlowCam, and (B) MFI.  Particle sta ndards were suspended in water as reference 
media R(), colored matrix C( ), opalescent matrix T( ), 35 FTU at 11 mPa*s TTV (), 30 FTU at 20 
mPa*s TTVV (), 16 FTU at 20 mPa*s TVV( ) and clear at 11 mPa*s V( ).The horizontal red lines 
represent 10% sensor resolution. See Table 5 for fu rther description of sample matrices. The 
horizontal red lines represent the calculated value s and the black horizontal lines are ±10% of the 
expected value. The error bars represent ±sd of n=4  independent measurements.   
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 polystyrene spheres borosilicate glass spheres “false protein particles” 
A 
B 
C 
Figure 20: Particle counts for polystyrene bead sta ndard particles (1st column), borosilicate glass 
bead standard particles (2nd column) and “false pro tein standards” (3rd column) using LO 
instruments (A) HIAC, (B) Syringe 670 nm, and (C) S yringe 780 nm.   Particle standards were 
suspended in water as reference media R( ), colored matrix C( ), opalescent matrix T( ), 35 FTU 
at 11 mPa*s TTV (), 30 FTU at 20 mPa*s TTVV (), 16 FTU at 20 mPa*s TVV( ) and clear at 11 
mPa*s V().The horizontal red lines represent 10% sensor res olution. See Table 5 for further 
description of sample matrices. The horizontal red lines represent the calculated values and the 
black horizontal lines are ±10% of the expected val ue. The error bars represent ±sd of n=4 
independent measurements.  
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Counting Precision 
As a characteristic parameter for determining particle counting precision, coefficients of 
variances (CV) were used which were calculated by dividing the standard deviation (sd) of n=4 particle 
count measurements obtained for a certain particle size range divided by the particle count average 
obtained for that size. The particle sizes examined in this study were equal to the sizes used in the 
previous section on particle counting accuracy. 
Equation 4: coefficient of variance for counting pr ecision 
 =    
When elucidating counting precision of measurements with polystyrene and glass particle bead 
standards (Figure 21), all methods showed repeatable results for the reference suspensions. A number 
of interesting relations are shown in Figure 21. However, these results have to be examined carefully 
due the small number of experiments and only few of the observations were considered to be of 
practical relevance as discussed below.  
As expected, counting reproducibility for glass particles was more affected by different solution 
properties than polystyrene particles. Solution turbidity and viscosity showed similar effects of lowering 
reproducibility. Counting precision using LO methods was less affected than MDI methods for measuring 
glass particles, which again may be attributed to the higher density of the glass particles, and therefore, 
a higher sink velocity. Using the “false protein standards”, counting reproducibility was 10% lower for 
MDI methods. LO methods showed slightly better reproducibility which decreased at higher particle size 
ranges, especially for counts ≥10 µm, however, one has to keep in mind that the LO method was only 
detecting a few particles at the higher size ranges. 
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Interestingly, suspensions containing colored solutions with glass particles were challenging in 
terms of FlowCam (FLO) and MFI reproducibility. In terms of solution viscosity, one could assume that 
the higher variability of particle counts at increased sample viscosity would most likely be due to 
potential air bubble formation during sample homogenization.  However, in this set of experiments, air 
bubbles were not observed for high viscosity samples and therefore particle counts did not noticeably 
increase. Lower reproducibility is not fully understood at this time, but may partially be attributed to 
homogenization problems due to difference in diffusion coefficients. 
 
 polystyrene spheres borosilicate glass spheres “false protein particles” 
A 
B 
Figure 21: Particle counting precision of n=4 indep endent measurements with MDI instruments (A) 
FlowCam (FLO), (B) MFI, for different particle stan dards suspended in water as reference media 
R(), colored matrix C( ), opalescent matrix T( ), 35 FTU at 11 mPa*s TTV (), 30 FTU at 20 mPa*s 
TTVV (), 16 FTU at 20 mPa*s TVV() and clear at 11 mPa*s V( ).The horizontal red lines 
represent 10% sensor resolution. See Table 5 for fu rther description of sample matrices.   
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 polystyrene spheres borosilicate glass spheres “false protein particles” 
A 
B 
C 
Figure 22: Particle counting precision of n=4 indep endent measurements with LO instruments  (A) 
HIAC, (B) Syringe with 670 nm laser (SY6), and (C) Syringe with 780 nm laser (SY7). Different 
particle standards were suspended in water as refer ence media R( ), colored matrix C( ), 
opalescent matrix T( ), 35 FTU at 11 mPa*s TTV (), 30 FTU at 20 mPa*s TTVV (), 16 FTU at 20 
mPa*s TVV() and clear at 11 mPa*s V( ).The horizontal red lines represent 10% sensor 
resolution. See Table 5 for further description of sample matrices.  
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Conclusions   
A small sample volume LO method was verified and compared to the larger volume USP/EP LO 
method for counting a variety of subvisible particles including polystyrene beads and aged mAb samples. 
Comparisons of LO and MDI methods were then carried out to determine the advantages and 
limitations for each analytical technique. Small sample LO and MFI resulted in differences in particle 
counts, however, these differences could not solely be attributed to the irregular shape and/or 
translucency of proteinaceous particles. For instance, MFI 5x counts for particles < 3 µm were 
significantly higher than for MFI 14x counts for the different particle types analyzed. Thus, MFI 5x 
particle counts at the lower particle size range should be verified with an alternative method, e.g. MFI 
14x. However, the MFI 14x method is lacking in terms of key parameters such as sampling efficiency and 
sufficient sample throughput. Though potential artifacts in MDI measurements may lead to higher 
particle counts in the 2 µm range, the reasons for the differences of MDI and LO measurements are still 
not fully understood and were further elucidated in subsequent studies. In contrast to previous 
publications, differentiation of particle types by shape analysis (mean intensity and circularity) using MFI 
was only possible for larger particles.
7
 Furthermore, differentiation of particle types based only on one 
shape parameter and using absolute data analysis filters remains challenging. A reliable differentiation 
of particles was only possible for particles > 5 µm or even > 10 µm and depended on factors such as 
their similarity, the chosen shape parameter, and the instrument type. For smaller particles, differences 
in shape parameters for various particle types could not be observed using MFI.  In summary, flow 
imaging techniques are helpful for characterization of the shape and morphology of sub-visible particles, 
but comparison of sub-visible particle counts and quantities between methods should be taken with 
care. In terms of particle shape analysis, picture quality is a key parameter when comparing different 
instruments. 
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A performance overview for the influence of sample fluid to counting and sizing abilities is given 
in Table 10 and Table 11. A number of conclusions can be drawn from these experiments studying the 
effect of variations of the sample matrix on particle counting, but only a few are considered to be the 
most relevant for practical applications: FlowCam showed low sizing and counting abilities compared to 
all other methods tested, most likely due to limitations in sampling efficiency and depth of the flow cell. 
Nevertheless, it was capable of recording higher quality particle pictures which can potentially better 
help to identify the particle origin. MFI images were sharper and more precise in terms of counting and 
sizing, but their picture quality appears lower due to lower pixel density per micron which is directly 
attributed to the magnification and the digital sensor (lower magnification) of the MFI.  All of the 
instruments achieved the required sizing resolution testing according to USP<788> with the exception of 
the  FlowCam instrument. Based on these results, LO remains the gold standard for the quantification of 
sub-visible particles in a QC environment, but MFI capabilities have greatly improved during the last few 
years and may in future also provide counting and sizing capabilities for QC use.  Currently, MFI still lacks 
LO in terms of sample efficiency and sample throughput. 
The effect of physical properties of sample matrices on the accuracy and precision of particle 
counting and sizing was examined in detail.  The coloration and turbidity of a solution had only a 
relatively small effect on particle sizing and counting ability.  However, whereas counting precision with 
the Syringe 780 nm and MFI instruments was significantly lower for 8 µm glass particle measurements in 
turbid media, particle sizing was not affected. The viscosity of a solution showed a pronounced influence 
on particle results, especially when using translucent glass particles or a non-uniform “false protein 
standard”. High viscosity samples may contribute to inaccurate particle counts due to air bubble 
formation, although air bubbles were not definitively imaged by MFI or FlowCam in this series of 
experiments. Viscosity also affects particle sizing accuracy for the HIAC method, especially when 
evaluating 5 or 10 µm polystyrene particles or 2 µm glass particles. 
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Viscosity mostly affected counting reproducibility; yet, only 4 independent measurements have 
been performed in the course of this study. Counting precision was most affected when testing the 
borosilicate glass bead standards using MFI or Syringe 670 nm instruments.  
Polystyrene standards are considered very robust against effects of sample matrix solution 
properties differing from water, and therefore are still considered the best option to calibrate these 
SbVP instruments. Nonetheless, new particle standards that better resemble protein particles, with well-
defined shapes and monodisperse sizes, would be very beneficial to quantitatively assess and 
understand the limitations of each of the analytical instruments. However, the reproducible generation 
and long term stability of these protein based particle standards remains a significant challenge. In 
summary, despite the availability of new MDI instruments, the detection and counting sub-visible 
protein based particles, especially particles of larger or equal than 2 µm, remains challenging, especially 
in a QC environment, depending on the instrument used, the solution properties, and the size and shape 
of the particles.   
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Table 10: performance overview of sample matrix inf luence for polystyrene particles standards 
suspended in water as reference media (R), colored matrix (C), opalescent matrix (T), 35 FTU at 11 
mPa*s (TTV), 30 FTU at 20 mPa*s (TTVV), 16 FTU at 2 0 mPa*s (TVV) and clear at 11 mPa*s (V). For 
the individual samples following key parameters are  shown: counting accuracy: the difference 
between the observed particle size (n=10000) and th e suppliers certified size in µm ( ∆Mø); sizing 
precision: the sensor resolution according to EP/US P in % (CVø); counting accuracy: the 
difference between the calculated value and the obs erved mean particle counts (n=4) in particles 
per ml ( ∆M#); counting precision the standard deviation devide d by the mean particle counts n=4 
individual measurements in % (CV#). The individual columns are colored in gradient from low to 
high performance ( ) 
  
Polystyrene particles 
 
2µm 5µm 10µm 
  
ΔMø CVø ΔM# CV# ΔMø CVø ΔM# CV# ΔMø CVø ΔM# CV# 
F
lo
C
a
m
 1
0
x
 
R 0.3 28% 586 3% 0.4 17% 515 2% 2.1 17% 697 5% 
C 0.2 29% 427 15% 0.3 16% 508 16% 2.1 16% 681 20% 
T 0.2 28% 480 4% 0.4 17% 562 3% 2.3 16% 815 4% 
TTV 0.5 28% 1396 24% 0.6 25% 642 9% 1.7 20% 962 5% 
TTVV 0.4 30% 673 11% 0.7 22% 465 9% 1.7 19% 733 13% 
TVV 0.4 27% 3267 69% 0.5 25% 1162 16% 1.6 19% 1493 18% 
V 0.1 28% 387 8% 0.1 17% 473 5% 1.7 16% 752 11% 
M
F
I 
5
x
 
R 0.7 26% 663 3% 0.2 9% 116 2% 0.0 6% 12 6% 
C 0.5 27% 530 3% 0.3 8% 179 4% 0.1 5% 95 5% 
T 0.5 26% 562 5% 0.3 8% 172 3% 0.1 5% 43 4% 
TTV 0.4 34% 19 3% 0.2 11% 396 13% 0.2 7% 413 16% 
TTVV 0.4 34% 109 3% 0.2 9% 381 4% 0.1 5% 536 2% 
TVV 0.6 30% 4 6% 0.2 11% 305 4% 0.1 6% 428 8% 
V 0.3 30% 229 1% 0.2 7% 179 2% 0.0 5% 148 5% 
H
IA
C
 
R 0.7 17% 108 2% 0.6 19% 357 3% 0.5 9% 481 4% 
C 0.7 17% 108 2% 0.6 17% 289 3% 0.5 9% 490 6% 
T 0.7 17% 81 1% 0.6 17% 314 2% 0.6 9% 491 3% 
TTV 0.7 14% 1176 31% 1.1 14% 435 7% 0.6 11% 313 6% 
TTVV 0.8 13% 189 3% 1.0 11% 220 3% 0.8 9% 157 4% 
TVV 0.8 13% 1347 1% 1.0 13% 424 4% 0.8 10% 268 6% 
V 0.7 12% 55 2% 1.0 12% 417 2% 0.5 10% 498 3% 
S
y
ri
n
g
e
 6
7
0
 n
m
 R 0.5 26% 140 1% 0.0 7% 27 0% 0.0 4% 30 2% 
C 0.4 27% 181 3% 0.1 7% 84 2% 0.0 4% 65 4% 
T 0.4 27% 181 2% 0.1 7% 82 2% 0.0 4% 51 1% 
TTV 0.5 32% 141 4% 0.0 9% 88 3% 0.1 5% 72 4% 
TTVV 0.4 32% 197 8% 0.1 8% 153 9% 0.2 5% 156 12% 
TVV 0.3 32% 228 8% 0.1 8% 186 8% 0.2 5% 207 8% 
V 0.3 26% 132 7% 0.1 8% 112 8% 0.1 5% 99 6% 
S
y
ri
n
g
e
 7
8
0
 n
m
 R 0.6 19% 27 1% 0.2 7% 5 1% 0.0 3% 46 1% 
C 0.5 19% 58 1% 0.2 6% 56 2% 0.0 2% 51 3% 
T 0.6 19% 96 1% 0.2 7% 91 1% 0.0 3% 86 1% 
TTV 0.6 24% 73 3% 0.3 11% 32 3% 0.1 7% 84 2% 
TTVV 0.7 21% 65 5% 0.0 10% 51 5% 0.1 6% 112 7% 
TVV 0.7 22% 23 2% 0.0 12% 54 2% 0.1 7% 152 2% 
V 0.6 18% 22 3% 0.3 11% 7 6% 0.0 7% 20 8% 
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Table 11: performance overview of sample matrix inf luence for borosilicate glass sphere 
standards suspended in water as reference media (R) , colored matrix (C), opalescent matrix (T), 35 
FTU at 11 mPa*s (TTV), 30 FTU at 20 mPa*s (TTVV), 1 6 FTU at 20 mPa*s (TVV) and clear at 11 
mPa*s (V). For the individual samples following key  parameters are shown: counting accuracy: 
the difference between the observed particle size ( n=10000) and the suppliers certified size in µm 
(∆Mø); sizing precision: the sensor resolution accordin g to EP/USP in % (CV ø); counting accuracy: 
the difference between the calculated value and the  observed mean particle counts (n=4) in 
particles per ml ( ∆M#); counting precision the standard deviation devide d by the mean particle 
counts n=4 individual measurements in % (CV#). The individual columns are colored in gradient 
from low to high performance ( ) 
  
Borosilicate glass spheres 
 
2µm 8µm 
  
ΔMø CVø ΔM# CV# ΔMø CVø ΔM# CV# 
F
lo
C
a
m
 1
0
x
 
R 0.1 33% 28 4% 1.0 18% 336 6% 
C 0.1 33% 7 7% 0.9 17% 283 9% 
T 0.1 31% 60 5% 1.0 18% 176 8% 
TTV 0.2 48% 1949 3% 1.7 15% 1360 2% 
TTVV 0.2 42% 310 58% 1.5 17% 169 46% 
TVV 0.1 38% 1170 29% 1.3 20% 143 27% 
V 0.2 36% 264 5% 0.7 16% 908 6% 
M
F
I 
5
x
 
R 0.3 14% 9 4% 0.3 7% 8 7% 
C 0.3 14% 168 10% 0.5 7% 350 29% 
T 0.3 15% 12 30% 0.4 6% 98 62% 
TTV 0.2 29% 441 17% 0.3 16% 477 26% 
TTVV 0.3 26% 184 19% 0.1 10% 125 24% 
TVV 0.3 29% 422 54% 0.2 14% 438 71% 
V 0.0 36% 71 27% 0.5 11% 11 52% 
H
IA
C
 
R 0.4 32% 312 4% 0.6 10% 366 2% 
C 0.4 31% 313 7% 0.7 8% 400 5% 
T 0.4 31% 272 5% 0.7 7% 377 4% 
TTV 0.6 24% 3589 4% 0.7 15% 716 12% 
TTVV 0.5 29% 191 58% 0.8 11% 103 73% 
TVV 0.5 31% 1699 10% 1.0 15% 1206 12% 
V 0.4 34% 432 32% 1.0 11% 502 42% 
S
y
ri
n
g
e
 6
7
0
 n
m
 R 0.0 32% 155 3% 0.0 4% 191 1% 
C 0.1 25% 50 2% 0.2 0% 185 2% 
T 0.1 25% 51 1% 0.2 0% 160 1% 
TTV 0.2 35% 8 53% 0.8 16% 619 61% 
TTVV 0.2 35% 355 69% 0.4 13% 26 87% 
TVV 0.2 38% 189 50% 0.6 14% 276 60% 
V 0.1 37% 310 8% 0.2 8% 101 8% 
S
y
ri
n
g
e
 7
8
0
 n
m
 R 0.0 34% 301 5% 0.0 9% 151 3% 
C 0.3 19% 152 3% 0.2 5% 141 3% 
T 0.3 18% 253 30% 0.2 6% 51 40% 
TTV 0.3 32% 197 28% 0.1 16% 269 33% 
TTVV 0.3 28% 197 3% 0.1 14% 305 4% 
TVV 0.4 30% 119 16% 0.1 12% 464 18% 
V 0.3 28% 305 17% 0.4 11% 25 20% 
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Next Steps / Outlook 
Several analytical aspects related to the testing and measuring of SbVP, for example by MDI and 
LO, warrant further investigation.  
FlowCam and MFI provide a great opportunity for particle characterization, while their ability for 
particle counting remains to be further validated, especially in a QC environment. In this context, image 
quality is a key parameter for morphological analysis of particles. Improving image contrast for 
translucent particles would be beneficial, e.g. by using phase contrast microscopy or darkfield 
microscopy implemented into the MDI. Though the limit of resolution due to diffraction is already been 
addressed, e.g. in photo activated localization microscopy, it will take some time for this technology to 
become applicable in flow microscopy.33,34  
Besides the improvement of image quality and MDI technology, some work should be 
investigated in terms of defining morphological parameters, including their relevance and application to 
therapeutic protein solutions. As demonstrated in this thesis, different particle types can only be 
resolved to a certain extent, even when considering recent improvements by combining more than one 
parameter.35    A so called “f-factor” was introduced recently, providing better capability to differentiate 
between silicone oil droplets and protein particles.35 With regards to counting and sizing protein-based 
particles in a QC environment, the need for the development of a stable reference standard, that 
resembles key properties of protein particles, has been suggested to help fully validate MDI instruments 
for particle counting. Various groups have started to characterize the different types of protein particles 
according to their origin and morphology.
36-38
 However, to date, polystyrene bead standards still remain 
the gold standard for instrument standardization, calibration, method development, verification and 
validation, especially for use in a QC environment. 
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